Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifluridine for mpox virus keratoconjunctivitis
jRCTs031240048Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trifluridine in mpox and Keratoconjunctivitis (KC), sponsored by Japan Agency for Medical Research and Development. Started Jun 2024; status: completed.
02
Drugs
trifluridine
03
Conditions
mpoxKeratoconjunctivitis (KC)
Beyond the preview
Go deeper on jRCTs031240048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240048.